News

FDA Approves ‘Breakthough’ Drug to Prevent HIV
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
FDA approves powerful HIV drug with the potential to end the epidemic in the U.S.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Harvard Medical School3d
2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
CVS Mail-Order Drug Bias Suit by HIV Patients Denied Class Nod
HIV/AIDS patients challenging CVS Pharmacy Inc.'s policy of distributing specialty drugs through the mail failed to secure ...
The Manila Times on MSN3d
HIV-prevention drug wins FDA approval
THE United States Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences' lenacapavir, a drug to be injected twice annually, for preventing HIV infection in adults and adolescents at ...
USFDA approves first HIV prevention shot needing only two doses a year
Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...
NBC New York4d
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The Food and Drug Administration has approved ... The shot is the first in a new class of antiretrovirals which block HIV from infecting and making new copies of itself inside the immune cells ...
Tripura CM mulls sex education in Class VIII-XII curriculum
Agartala: Tripura CM Manik Saha on Friday said the state govt is considering the introduction of sex education in the ...
CNBCTV183d
US FDA approves Gilead's twice-yearly injection for HIV prevention
Gilead has plans for a rapid launch in the United States as well as a wider rollout of the drug in collaboration with global ...